Crohn’s disease treatment market sees major shift with biosimilars and next-gen therapies:…
The recent launch of adalimumab biosimilars not only will cause an overall reduction in the cost of treatment, but also provide…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
adalimumab
Humira biosimilar to see $832 million in sales by 2029: GlobalData
Humira’s 52-week study evaluated adalimumab’s efficacy and safety for moderate-to-severe psoriasis, exploring continuous against…
Enzene Biosciences begins commercial supply of its biosimilar of Adalimumab
This is the company’s fourth biosimilar launch in recent times
Cadila Pharma launches Cadalimab (adalimumab biosimilar) for India
It is used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and psoriasis
Anti-TNF therapies could treat patients with COVID-19-related ARDS
This would reduce COVID-19 mortality, as about 17 of COVID-19 patients develop ARDS, states GlobalData